Objectives: Two carbapenemase-carrying plasmids, pLS488 (bla ) and pLS535 (bla ) from Acinetobacter pittii clinical isolates, were characterized in this study, including their ability to be transferred to Acinetobacter baumannii.
Introduction
Carbapenem resistance in Acinetobacter spp. has been mostly associated with the production of OXA-23, OXA-24/40 and OXA-58 carbapenem-hydrolysing class D b-lactamases (CHDLs). 1, 2 The spread of these CHDLs among Acinetobacter baumannii has been strongly influenced by clonal expansion, but also by horizontal gene transfer (HGT). 1, 3 However, the contribution of HGT to the spread of CHDL among other Acinetobacter species, in particular Acinetobacter pittii, which is increasingly reported in clinical settings (mainly in Asia, but also in Europe and America, and was recently described in Portugal in lettuce, fruits and raw meat), 2, 4, 5 has scarcely been explored. To date, only one complete bla OXA-58 -carrying plasmid sequence (pOXA58-AP_882) has been described for this species, with no descriptions of bla OXA-23 -associated plasmids. 6 In order to obtain new insights into the contribution of A. pittii mobile elements to CHDL dissemination, we report here the characterization of two carbapenemase-carrying plasmids, pLS488 (bla ) and pLS535 (bla ), exploring at the same time their ability to be transferred to A. baumannii.
Materials and methods

Bacterial strains, susceptibility testing and carbapenemase detection
The clinical isolates included in this study were obtained from a Portuguese university hospital that has experienced an endemicity of carbapenemaseproducing A. baumannii for several years. In more recent years, an increase was observed in the frequency of non-A. baumannii species associated with infection and colonization. Thus, following a surveillance screening for carbapenemase producers among non-A. baumannii isolates, two A. pittii isolates (HGSA488 and HGSA535), collected 3 months apart and presenting decreased susceptibility to carbapenems, were further characterized. HGSA488 was isolated in 2012 from drainage fluid of a patient with biliary tract cancer admitted to the surgery unit, and HGSA535 was isolated from an exudate of a patient with hip infection admitted to the orthopaedic unit. These isolates were initially misidentified as A. baumannii by the VITEK 2 system (bioMérieux), but were confirmed as A. pittii by MALDI-TOF MS and rpoB/gyrB partial gene sequencing. 7, 8 Antimicrobial susceptibility profiles of different b-lactams, aminoglycosides, tetracyclines, quinolones, trimethoprim/sulfamethoxazole and colistin were obtained by standard disc diffusion, Etest (carbapenems) and broth microdilution (colistin) Carbapenemase production was assessed by the Blue-Carba biochemical assay. 10 CHDL genes were searched for by PCR sequencing, using primers and conditions previously described. 11 Their genetic location and plasmid size were assessed by hybridization of S1 gels with specific probes. Genetic relatedness was characterized by ApaI-PFGE and MLST (Oxford and Pasteur Schemes).
WGS, assembly and plasmid sequence analysis
Total DNA from HGSA488 and HGSA535 was extracted using the Wizard Genomic DNA purification kit (Promega Corporation, Madison, WI) according to the manufacturer's instructions. DNA concentration was estimated using a Qubit dsDNA HS Assay Kit and a Qubit 3.0 Fluorometer (Invitrogen, Thermo Fisher Scientific, USA). Extracted DNA was then sequenced with a standard 2%125 paired-end runs protocol on an Illumina HiSeq 2000 (Illumina, San Diego, CA, USA). The quality of the high-throughput sequence data was assessed by FastQC (http://www.bioinformatics.babraham.ac.uk/projects/ fastqc/). Raw sequence reads were then de novo assembled using plasmidSPAdes 3.9.0 (http://bioinf.spbau.ru/spades), 12 in order to identify plasmid contigs, and the quality was assessed by QUAST (http://quast.bioinf. spbau.ru). The draft plasmids were automatically annotated with RAST (http://rast.nmpdr.org) and further manually curated by Geneious v. 9.1.6. (Biomatters Limited, Auckland, New Zealand) using BLASTn/BLASTp (https:// blast.ncbi.nlm.nih.gov/Blast.cgi). Conventional PCRs with further Sanger sequencing of amplicons were performed for plasmid circularization [primers pLS488_F (AACCCCACACTACCATCAGC), pLS488_R (CGCTAGGATTCTCTTCAG CTGA), pLS535_F (TGCAAGCATCTACAGTGCCT) and pLS535_R (AGTTGA GGATCAGAACGTAGGG)] and for the detection of the new replicase found in plasmid pLS488 [primers rep_pLS488_F (GTGTTTTGCGGCTTGTTGGA) and rep_pLS488_R (TTGGGTCTTTTTGGCTCGGT)], following the same PCR conditions proposed by Bertini et al. 13 Complementary gene identification analysis was done using ISfinder (https://www-is.biotoul.fr), ResFinder (https://cge.cbs. dtu.dk/services/ResFinder/) and the Virulence Factors of Bacterial Pathogens database (http://www.mgc.ac.cn/VFs/main.htm).
Mating and electrotransformation experiments
Transfer of plasmids carrying carbapenemase genes was attempted by standard conjugation (filter-mating method at a 1:1 donor/recipient ratio, 37 C) and electroporation assays, using a rifampicin-resistant mutant of A. baumannii ATCC 17978 as a recipient strain. Presumptive transconjugants were selected using Mueller-Hinton II agar plates supplemented with imipenem (0.5 mg/L) and rifampicin (100 mg/L), and presumptive transformants were selected with imipenem (0.5 mg/L). Confirmation was performed with antibiogram and PCR search for carbapenemase genes.
Nucleotide sequence accession numbers
The complete nucleotide sequences of pLS488 and pLS535 plasmids have been submitted to GenBank under accession numbers MF078634 and MF078635, respectively.
Results and discussion
General features of HGSA488 and HGSA535 isolates HGSA488 displayed an MDR phenotype, 14 being resistant to all b-lactams tested (carbapenems MICs .32 mg/L), except ceftazidime, and susceptible to all non-b-lactams (including colistin, MIC " 0.5 mg/L). This isolate was Blue-Carba positive and presented bla OXA-23 associated with plasmid pLS488 (Figure 1 ). HGSA535 displayed resistance to almost all b-lactams (piperacillin, piperacillin/tazobactam, ticarcillin, amoxicillin/clavulanic acid, aztreonam, cefotaxime and ceftriaxone), except cefepime, ceftazidime, imipenem (MIC " 2.0 mg/L) and meropenem (MIC " 0.75 mg/L), and was susceptible to almost all non-b-lactams (including colistin, MIC " 0.25 mg/L). It is notable that although this isolate was Blue-Carba negative and the imipenem MIC was lower than the clinical resistance breakpoint (4-8 mg/L), it was higher than the epidemiological cut-off value (ECOFF) (1 mg/L), which suggested the acquisition of a carbapenem resistance mechanism, further confirmed by WGS as bla OXA-58 , which is associated with plasmid pLS535 (Figure 2) . Besides the bla OXA-23 and bla OXA-58 genes identified, respectively in HGSA488 and HGSA535 isolates, other resistance genes were detected in both genomes, including the natually occurring A. pittii b-lactamases bla OXA-500 and bla . 15 The presence of several genes previously associated with virulence in A. baumannii was also observed; these genes were linked to biofilm formation (adeG, csuD, bap), immune evasion (lpsB, lpxA, lpxB, lpxC, lpxD, lpxL), iron uptake systems (barAB, basA, basB, basD, bauA, entE, hemO), serum resistance (pbpG), outer membrane protein phospholipase (plcC) and quorum sensing (abaI, abaR, bfmRS), which can confer an advantage for the maintenance of this lineage in clinical settings. Both isolates belong to ST1030/ST93 (Oxford and Pasteur schemes, respectively) and present the same ApaI-PFGE band pattern (data not shown).
Characterization of plasmid pLS488
The de novo assembly of the A. pittii HGSA488 produced a single 51316 bp contig, which corresponded to the pLS488 plasmid. This plasmid was further closed by PCR and sequencing of the amplicons, with a final length of 51291 bp, in agreement with the result obtained from S1 nuclease PFGE-based sizing (51 kb, data not shown). This plasmid comprises 50 ORFs, including genes associated with a transposon structure harbouring bla OXA-23 (Tn2008) and presenting a GC content of 35.5% (Figure 1 ), a value compatible with the GC content of A. pittii genome.
The plasmid pLS488 backbone was highly related (81% query cover, 99% identity) to a previously described bla OXA-23 -harbouring plasmid from an A. baumannii strain isolated from the urine of a hospitalized cat with cystitis in Germany (pIHIT7853, GenBank: KX118105.1). The similarity between these plasmids without any known relationship between the isolates suggests that these could be widely disseminated in animals and humans all over the world. On both plasmids, bla OXA-23 is embedded in a Tn2008 transposon, flanked by an ATPase gene downstream and a complete ISAba1 27 bp upstream of bla [with inverted and double-mutated inverted repeat left (IRL) and inverted repeat right (IRR)]. Tn2008 was also described in several clinical A. baumannii isolates, predominantly in China and the USA, though generally without characterization of the genetic background. 16, 17 Curiously, our previous local epidemiology studies 18 showed that OXA-23 has been associated with a different genetic background from the one here described, always being located in transposon Tn2006 on chromosomes of A. baumannii species. Also similar to pIHIT7853, pLS488 displayed a DNA primase (99% identity), involved in DNA replication, the conserved replication module comprising the characteristic parABpartitioning operon and the plasmid replicase [94% identity with the one from pIHIT7853 (accession number KX118105.1)] that ensure the maintenance and inheritance of the plasmid. However, Characterization of bla OXA-23 -and bla OXA-58 -carrying plasmids JAC unlike those found in other Acinetobacter plasmids (mainly repAci6 plasmids), the replicase (rep) of our plasmid and of pIHIT7853 belong to the superfamily RdgC, a family of DNA-binding proteins that modulate the activity of the RecA recombinase, which is involved in replication and homologous recombination processes. RdgC proteins are restricted to the b-and c-subsections of Proteobacteria, mainly found in Escherichia coli, Salmonella enterica and Klebsiella pneumoniae, but also in Pseudomonas spp. These two rep genes may represent a new replicase group (suggesting higher plasmid diversity among Acinetobacter species) not included in the A. baumannii PCR-based replicon typing scheme proposed by Bertini et al. 13 Thus, we designed an additional pair of primers to detect a 482 bp fragment that can simplify the identification of this replicase among other Acinetobacter plasmids. pLS488 also contains a helicase, a resolvase and a restriction endonuclease, enzymes not found in pIHIT7853.
Genes of the conjugation system, including the origin of transfer gene (oriT), the MOB P -type relaxase gene (traI) and the type IV coupling protein (T4CP) gene (virD4/traG) for initiation of conjugation, as well as markers of the type IV secretion system (T4SS), including the translocation channel protein genes (virB3/trbD, virB6/trbL, virB8/trbF, virB9/trbG and virB10/trbI), the pilus protein genes (virB2/trbC and virB5/trbJ) and the ATPase genes (virB4/trbE, virB11/trbB and virD4/traG), were also present, indicating that pLS488 is conjugative. To our knowledge, this is the first conjugative plasmid reported so far to carry a carbapenem resistance gene in A. pittii. Consistent with this, attempts to obtain OXA-23-producing A. baumannii transconjugants were successful [with co-transferred resistance to all b-lactams (carbapenem MICs .32 mg/L)], emphasizing the importance of A. pittii isolates as a source of resistance genes.
Characterization of plasmid pLS535
The de novo assembly of the A. pittii HGSA535 genome produced a single 11818 bp contig, which corresponded to the pLS535 plasmid. This plasmid was further closed by PCR and sequencing of the amplicons to give a final length of 11388 bp, in agreement with the result obtained from S1 nuclease PFGE-based sizing (11 kb, data not shown). This plasmid comprises 16 ORFs, presents a GC content of 33.7% ( Figure 2 ) and has substantial nucleotide differences (34%-37% QC, 98%-99% identity) from other bla OXA-58 -harbouring plasmids, such as the A. pittii plasmid pAG304 (accession number JQ241790.1), previously described in China, but also with plasmids of other Acinetobacter species, such as pWA3 (accession number JQ241791.1) and pAba3207a (accession number NZ_CP015365.1) from A. baumannii isolates (China and Mexico, respectively) and pXBB1-9 (accession number NZ_CP010351.1) from an Acinetobacter johnsonii isolate (China). The common fragments included the transcription regulator araC1 and the threonine efflux protein lysE, and also genes associated with the platform where OXA-58 is embedded: in the right-hand extremity, with a complete copy of ISAba3 identified 30 bp downstream of the stop codon of bla OXA-58 ; and in the left-hand extremity, with an inverted Figure 1 . Schematic representation of plasmid pLS488 of A. pittii strain HGSA488. Broad arrows in the outer circle indicate genes coding for resistance factors (orange), conjugative transfer genes (blue), replication module (yellow), insertion sequences/mobile elements (green), other factors (red) and hypothetical proteins (grey). orf1, DNA primase; orf2, resolvase Ser-recombinase superfamily; orf3, restriction endonuclease subunit R; orf4, DNA methylase; orf5, helicase. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
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DISAba3, identified 20 bp upstream of the start codon of bla OXA-58 . This DISAba3 was truncated 427 bp after the start codon of the transposase gene of ISAba3; this was caused by the C terminus being replaced by the point-mutated IRL of ISAba32 (found in pD36-4, a sul2-harbouring A. baumannii plasmid).
Flanking the bla OXA-58 locus (downstream of the lysE gene and 6 bp upstream of the IRL of ISAba32) were two Re27 sequences (ATTTAACATAATGGCGGTTATACGAAG and ATTTAACATAATGGCTGT TATACGAAA), suggesting that a recombination process was responsible for the acquisition of the bla OXA-58 locus and might explain the interruption in ISAba32. Inside the DISAba3, promotor sequences (TTTCTT and TTCTTT) were found, accounting for the expression of OXA-58 and the imipenem MICs being higher than the ECOFF.
On the right-hand end of Re27, a putative VapC-MazE toxinantitoxin system of the type II module was found.
Even though this plasmid lacked the machinery for conjugation, which explains the failure of the conjugation experiments, we were able to transfer it by electroporation, with A. baumannii transformants acquiring resistance to all b-lactams (carbapenems MICs .32 mg/L).
Unlike the bla OXA-58 -carrying A. pittii plasmids (mainly associated with rep types Aci9, Aci10 and repB) 6, 19, 20 and the bla OXA-58 -carrying A. baumannii plasmids from European countries (mostly associated with repAci1), 21 the replicase protein of this plasmid belongs to the Rep3 superfamily (GR7 incompatibility group) and shared 82% nucleotide identity with replicase p3ABSDF0002 from plasmid p3ABSD, as described in France (accession number CU468233.1).
Conclusions
In this study we characterized two new CHDL-carrying A. pittii plasmids, pLS488 and pLS535. pLS488 is the first conjugative plasmid associated with a carbapenem resistance gene reported in A. pittii and belongs to a potential new incompatibility group, which may also contribute to the dissemination of OXA-23 among A. baumannii. pLS535 presents a new scaffold associated with OXA-58. In addition, both isolates represent the first report, to our knowledge, of CHDLcarrying A. pittii in Portuguese hospitals. This study also highlights the potential of A. pittii, or a particular A. pittii clone, to acquire and act as a source of CHDL resistance genes, with the ability to integrate different genetic backgrounds and the potential for further dissemination.
